From usenet.ucs.indiana.edu!sol.ctr.columbia.edu!howland.reston.ans.net!darwin.sura.net!lhc!void!lipman Fri May 7 14:51:01 EST 1993 Article: 1721 of bionet.general Newsgroups: bionet.general Path: usenet.ucs.indiana.edu!sol.ctr.columbia.edu!howland.reston.ans.net!darwin.sura.net!lhc!void!lipman From: lipman@void.nlm.nih.gov (David Lipman) Subject: Direct Submissions to GenBank Message-ID: <1993May7.173318.24875@nlm.nih.gov> Sender: news@nlm.nih.gov Organization: National Library of Medicine X-Newsreader: Tin 1.1 PL4 Date: Fri, 7 May 93 17:33:18 GMT Lines: 51 [The following is based on a letter dated May 5 that has been sent to AuthorIn users and recipients of the NCBI newsletter] Dear GenBank User, Since assuming responsibility for GenBank in October of 1992, the National Center for Biotechnology Information (NCBI) has continued its efforts to improve the database and to facilitate user access. During this period, CD-ROM and network access has increased by nearly an order of magnitude. Ongoing initiatives for improving the database include: - Increasing the breadth of coverage by scanning Medline's 3500 journals and by incorporating new sources of sequences, such as the Protein Data Bank (PDB) and the Protein Research Foundation database (PRF); - Adding Medline information to sequence entries; - Resolving inconsistencies among source databases, such as conflicts between GenBank and EMBL; - Minimizing redundancy; - Providing new methods for network access to the data. As part of these ongoing efforts, over the next year NCBI will be assuming a larger role in the processing of direct author submissions and updates. Beginning on May 17, 1993, direct submissions should be sent to NCBI: U.S. mail (for submissions on diskette, indicate whether Mac or PC): GenBank Submissions National Center for Biotechnology Information Bldg. 38A, Room 8N-803 8600 Rockville Pike Bethesda, MD 20894 E-mail submission of new sequences: gb-sub@ncbi.nlm.nih.gov E-mail submission of updates: update@ncbi.nlm.nih.gov NCBI and Los Alamos National Laboratory (LANL) have arranged to work together to process direct submissions. Our goal is to continue to enhance the value of the database through the direct contributions of authors and, towards this end, we are developing new methods to submit and update sequence information. We appreciate your input on how we may improve the database and access to it. We invite you to send your suggestions to 'info@ncbi.nlm.nih.gov'. David J. Lipman Director, NCBI/NLM